Skip to main content
Fig. 1 | BMC Bioinformatics

Fig. 1

From: Immunoinformatics design of multi-epitope vaccine using OmpA, OmpD and enterotoxin against non-typhoidal salmonellosis

Fig. 1

A. The final schematic multi-epitope vaccine with 237 amino acids. The adjuvant (Griselimycin) sequence was linked by EAAAK linker at both N and the C terminal of the vaccine the B cell, HTL and CTL epitopes were connected by GPGPG and AYY linkers respectively. B. The prediction of secondary structure and solubility of vaccine constructs. C. The analysis of secondary structure in SOPMA tool shows that the vaccine contains 36.29% alpha-helix, 13.08% extended strands, 6.75% beta turns and 43.88% random coils

Back to article page